Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
98.73
-3.51 (-3.43%)
Aug 20, 2026, 11:42 AM EDT - Market open
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Mirum Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $138.21. The average 1-year stock price forecast is 39.99% higher than the current stock price, while the lowest is $118 (+19.52%) and the highest is $183 (+85.35%).
Price Target: $138.21 (+39.99%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Mirum Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 9 | 10 | 10 | 10 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 13 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $140 | Buy | Maintains | $140 | +41.80% | Aug 20, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $118 | Buy | Maintains | $118 | +19.52% | Aug 11, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $140 | Buy | Maintains | $140 | +41.80% | Aug 10, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $136 | Buy | Maintains | $136 | +37.75% | Aug 6, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $129 → $123 | Buy | Maintains | $129 → $123 | +24.58% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
696.58M
from 521.31M
Increased by 33.62%
Revenue Next Year
815.98M
from 696.58M
Increased by 17.14%
EPS This Year
-15.14
from -0.47
EPS Next Year
-0.35
from -15.14
EPS and Forward PE are based on non-GAAP adjusted numbers.